M3 Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Sell
427
-79
-16% -$37.9K 0.11% 144
2026
Q1
$249K Buy
506
+11
+2% +$5.97K 0.15% 118
2025
Q4
$287K Sell
495
-154
-24% -$87.1K 0.17% 96
2025
Q3
$315K Buy
649
+99
+18% +$46.1K 0.2% 91
2025
Q2
$223K Buy
550
+14
+3% +$5.85K 0.15% 128
2025
Q1
$267K Sell
536
-124
-19% -$67.2K 0.21% 101
2024
Q4
$343K Sell
660
-371
-36% -$204K 0.25% 82
2024
Q3
$638K Buy
1,031
+447
+77% +$265K 0.47% 45
2024
Q2
$323K Buy
584
+35
+6% +$20.1K 0.27% 88
2024
Q1
$319K Buy
549
+8
+1% +$4.49K 0.29% 82
2023
Q4
$287K Buy
+541
New +$262K 0.34% 70

Other funds holding TMO

M3 Advisory Group's TMO Position: Q2 2026 in Review

M3 Advisory Group reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, selling an estimated $37.9K and leaving 427 shares worth $214K. The position accounts for 0.11% of the portfolio, ranked #144.

M3 Advisory Group first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $638K in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • M3 Advisory Group held 427 shares of Thermo Fisher Scientific worth $214K as of Q2 2026.
  • M3 Advisory Group sold 79 Thermo Fisher Scientific shares in Q2 2026, an estimated $37.9K.
  • Thermo Fisher Scientific made up 0.11% of M3 Advisory Group's portfolio in Q2 2026, its #144 holding.
  • M3 Advisory Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • M3 Advisory Group's Thermo Fisher Scientific position peaked at $638K in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on M3 Advisory Group's 13F filing for Q2 2026, filed 24 Jul 2026.